Macular Thickness Measurements Using Retinal-thickness OCT

Macular Thickness Measurements Using RTOCT

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03030729

Enrollment

Registered

2017-01-25

Start date

2017-03-14

Completion date

2018-01-14

Last updated

2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-Related Macular Degeneration, Diabetic Retinopathy

Brief summary

Comparison between retinal measurements, done by the RT (Retinal Thickness) imaging and a commercial OCT (Optical Coherence Tomography)

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Ability and agreement to give informed consent (IC) 2. Diagnosis of AMD or DR in SE by OCT 3. Ability to undergo OCT scans

Exclusion criteria

1. AMD and DR in the same SE 2. Evidence of macular disease other than AMD or DME in SE

Design outcomes

Primary

Measure	Time frame
Comparison between retinal measurements, done by the RTOCT device and a commercial OCT	1 year

Countries

Israel

Outcome results